Obtaining optimum corneal tissue for transplant

Article

A team in the Philippines has defined criteria that need to be met in order to obtain an optimum tissue quality for corneal grafts.

A team in the Philippines has defined criteria that need to be met in order to obtain an optimum tissue quality for corneal grafts. The quality of corneal grafts can be affected by factors including the time and season of the post-mortem graft harvest, according to the study.

Dr Charish F. Daffon and colleagues conducted a retrospective review of corneal donor records (n=1955) from 2000–2005 and tabulated donor data to establish criteria for harvesting optimal corneal buttons for tissue eye banking. Data on 2797 corneal buttons were analysed.

The team found that factors influencing endothelial corneal rating and overall button quality were age of donor (≤32 years for optimum quality), duration of time between death and preservation (≤7.1 hours for optimum tissue quality - note that this is significantly shorter than the internationally recognised 12-hour standard), technician extracting the tissue and month of harvest (December–February).

The researchers concluded that there are several factors governing the quality of corneal tissue extracted post-mortem for transplantation.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.